arrow
P

Pierre Bigot

Urology Department
H指数:30
被引数:3,041

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Assessment of Infectious Risk Factors in Benign Prostatic Hyperplasia Surgery: Results of the French Multicenter TOCUS Study

良性前列腺增生手术中感染风险因素的评估:法国多中心TOCUS研究的结果

2026-01-010
OAAI
Clinical and Pathological Features Associated with Chromophobe Renal Cell Carcinoma Recurrence: Analysis from a Nationwide Cohort

与嗜色细胞肾细胞癌复发相关的临床和病理特征:全国队列分析

2025-11-130
OAAI
Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial

度伐利尤单抗联合BCG用于BCG-naive高危非肌层浸润性膀胱癌(POTOMAC):一项随机、开放标签、III期试验的最终分析

2025-10-170
PRE
Racial differences in kidney cancer histology and outcome: A nationwide study from the UroCCR Cohort

肾癌组织学特征与预后的种族差异:一项来自UroCCR队列的全国性研究

Cancer
IF5.1
2025-10-080
OAAI
Updated 2025 French guidelines for renal cell carcinoma
2025-10-010
OAAI
Clinical Trial Protocol for ACCURATE: A CCafU-UroCCR Randomized Trial: Three-dimensional Image-guided Robot-assisted Partial Nephrectomy for Renal Complex Tumor (UroCCR 99)

ACCURATE临床研究方案:一项CCafU-UroCCR随机试验:三维影像引导机器人辅助肾部分切除术治疗肾复杂肿瘤(UroCCR 99)

2025-04-070
PRE
Investigation of whether renal tumours with caval thrombi induce particular risks: a multicentre study (UroCCR-174 CAVORISK)
2025-04-010
PRE
Robot-assisted Partial Nephrectomy for Hilar and Nonhilar Renal Masses: Comparison of Perioperative, Oncological, and Functional Results in a Multicentre Prospective Cohort (NEPRAH Study, UroCCR 175)
2024-12-010
PRE
Impact of antibiotic treatment duration for preoperative asymptomatic bacteriuria, during urological surgery, on postoperative infectious complications: results from the multicentric TOCUS cohort
2024-11-010
PRE
Oncologic surveillance after surgical treatment for clinically localized kidney cancer: UroCCR study n. 129

临床局部肾癌手术治疗后的肿瘤学监测: UroCCR研究n。129

2024-09-011
PRE
Nivolumab in patients with advanced renal cell carcinoma in France: interim results of the observational, real-world WITNESS study

法国晚期肾细胞癌患者的Nivolumab: 观察性,真实世界WITNESS研究的中期结果

2024-07-011
OAAI
Preparing for the Worst: Management and Predictive Factors of Open Conversion During Minimally Invasive Renal Tumor Surgery (UroCCR-135 Study)
2024-05-011
OAAI
Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions

肾癌的多祖先全基因组关联研究确定了63个易感区域

2024-04-262
PRE
The Impact of Histological Variants on Oncological Outcomes After Surgical Resection of a Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus: A Multi-institutional Study

非转移性肾细胞癌伴癌栓手术切除后组织学变异对肿瘤学结局的影响: 一项多机构研究

2024-04-011
OAAI